INNOVATE Corp. Common Stock (VATE)
Fast GrowerFairStock Score: 47/100 — MIXED
Key Financials
| Current Price | $10.66 |
| Market Cap | $161M |
| P/E Ratio | -2.51 |
| ROE | —% |
| Dividend Yield | 9.62% |
| Sector | Industrials |
Strengths
- Generates $127 million in annual free cash flow (78.8% yield on market cap)
- Strong Piotroski F-Score of 8/9 indicating robust financial health across profitability, leverage, and efficiency metrics
- Revenue growth of 61.8% demonstrates strong top-line momentum
- Attractive 9.6% dividend yield providing steady income returns
Concerns
- Currently unprofitable—sustained losses could lead to dilutive capital raises or balance sheet deterioration
- Altman Z-Score of -1.1 places it in the financial distress zone—elevated bankruptcy risk
AI Analysis
INNOVATE Corp. Common Stock is a micro-cap industrials company valued at $161 million. Revenue stands at $1.2 billion, though the company is currently unprofitable. From a quality standpoint, INNOVATE shows near-perfect Piotroski F-Score of 8/9 indicating exceptional financial health and distressed Altman Z-Score of -1.1 warrants caution. On valuation, the stock is strong 58.0% free cash flow yield. Growth dynamics show revenue growing at 61.8% and profit growth of 55.4%. The 9.6% dividend yield adds an income component for patient holders. Our composite FairStock Score of 47/100 reflects mixed fundamentals overall. Without profitability, this remains speculative—suitable only for those with high risk tolerance and a long time horizon.
Bull Case
INNOVATE's 62% revenue growth trajectory could accelerate as it captures additional market share in the industrials sector. With $127 million in annual free cash flow (78.8% yield), management has ample capital for buybacks, dividends, or accretive acquisitions.
Bear Case
Without a clear path to profitability, continued cash burn forces either dilutive equity raises or debt accumulation that destroys shareholder value. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.
Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer